Amgen To Open Manufacturing Site In Central Ohio; To Offer 400 Full-time Jobs

Amgen's Bkemv Approved As First Interchangeable Biosimilar To Soliris

The U.S. Food and Drug Administration has approved Amgen Inc.'s Bkemv (eculizumab-aeeb) as the first interchangeable biosimilar to Soliris (eculizumab), developed by British drug major AstraZeneca's Rare Disease unit Alexion Pharmaceuticals, to treat certain rare diseases. Soliris is a medicine used to treat adults and children with paroxysmal nocturnal haemoglobinuria or PNH...

RTTNews | Před 533 dny

Amgen Says FDA Completes Review Of SNDA Seeking Full Approval For LUMAKRAS

Amgen, Inc. (AMGN) announced Tuesday that the U.S. Food and Drug Administration (FDA) has completed its review of the company's supplemental New Drug Application seeking full approval of LUMAKRAS (sotorasib).

RTTNews | Před 689 dny

Amgen, Horizon Therapeutics Reach Settlement On FTC Lawsuit; Seeks To Close Acquisition In Q4

Amgen (AMGN) and Horizon Therapeutics plc (HZNP) announced Friday the entry into a consent order agreement with the Federal Trade Commission (FTC) that resolves the pending FTC administrative lawsuit. This clears the path to take the final steps to close Amgen's $27.8 billion acquisition of Horizon.

RTTNews | Před 804 dny

Amgen Announces Positive Top-line Results From Phase 3 DAHLIA Study Of ABP 959

Amgen, Inc. (AMGN) announced Tuesday positive top-line results from the DAHLIA study, a randomized, double-blind, active-controlled, two-period crossover Phase 3 study evaluating the efficacy and safety of ABP 959, a biosimilar candidate to SOLIRIS (eculizumab), compared with SOLIRIS in adult patients with paroxysmal nocturnal hemoglobinuria (PNH).

RTTNews | Před 1179 dny

European Shares Extend Losses On Economic Concerns

European stocks traded lower on Friday, extending losses from the previous session as investors fretted about an artificial intelligence bubble and the outlook for U.S. interest rates.

RTTNews | Před 1 h 10 min

China Industrial Output, Retail Sales Growth Eases

China industrial production and retail sales grew at weaker rates in October and investment downturn deepened as economic activity weakened towards the end of the year. Industrial production logged an annual growth of 4.9 percent in October, the National Bureau of Statistics said Friday. This followed September's 6.5 percent expansion.

RTTNews | Před 1 h 47 min

Asian Shares Follow Wall Street Lower Amid Tech Valuation Concerns

Asian stocks followed Wall Street lower on Friday as investors fretted about lofty tech valuations and the U.S. economic outlook.

RTTNews | Před 1 h 57 min

NZ Dollar Rises After China Economic Data

The New Zealand dollar strengthened against other major currencies in the Asian session on Friday, following the release of the China retail sales and industrial production data in October.

RTTNews | Před 2 h 31 min

EURUSD	1.16272	GBPUSD	1.31613	AUDUSD	0.6524
USDJPY	154.623	USDCAD	1.40329	USDCHF	0.7917